SUJITH RAVI

@srmist.edu.in

Assistant Professor, Department of Microbiology, Faculty of Medicine and Health Sciences,
SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology

SUJITH RAVI


                  Download Compact PDF  
https://researchid.co/sujithsrisurya

RESEARCH INTERESTS

Medical Microbiology
25

Scopus Publications

563

Scholar Citations

9

Scholar h-index

9

Scholar i10-index

Scopus Publications

  • Diagnostic and therapeutic challenges in melioidosis: a case series from South India
    Dakshina M. Nair, Anusha Gopinathan, Kanya R., Leela Kakithakara Vajravelu, Chiranjay Mukhopadhyay, R. Santharam, Sujith Sri Surya Ravi, Datchamoorthy Maheswary, S.S. Jayalakshmi
    Reviews and Research in Medical Microbiology, 2026
    Burkholderia pseudomallei is a Gram-negative, bipolar-staining bacillus and the causative agent of melioidosis, a potentially fatal infectious disease endemic to tropical and subtropical regions. We present a case series of three patients with culture-confirmed B. pseudomallei infection admitted to a tertiary care hospital, all of whom presented with septicaemia. Microbiological diagnosis was established using culture and confirmed via VITEK-2 Compact system and PCR targeting the T3SS1 gene. Timely initiation of appropriate antibiotics, ceftazidime or meropenem followed by eradication therapy with trimethoprim-sulfamethoxazole led to favourable outcomes.
  • Role of Candida albicans in chronic inflammation and the development of oral squamous cell carcinoma
    Malavika G, Sujith Sri Surya Ravi, Datchanamoorthy Maheswary, Kakithakara Vajravelu Leela, Rahul Harikumar Lathakumari, Lekshmi Priya K S
    Cancer Pathogenesis and Therapy, 2025
    Oral cancer pathogenesis is significantly influenced by Candida species, especially C. albicans , through chronic inflammation and cellular dysregulation. Epidemiological studies highlight a strong correlation between persistent Candida infections and oral carcinogenesis. Experimental evidence has identified key biomolecular mechanisms, including biofilm formation, epithelial invasion, and immune evasion. Chronic inflammation induced by Candida fosters a pro-tumorigenic environment characterized by oxidative stress, cytokine imbalance, and genomic instability. Animal models of Candida -induced oral lesions offer insights into premalignant conditions, and case series studies further support the association between fungal infections and oral cancer. This review critically examines the role of Candida , particularly C. albicans , in oral squamous cell carcinoma (OSCC) pathogenesis by analyzing epidemiological, experimental, and mechanistic data. We emphasize the importance of early detection and therapeutic strategies, including antifungal prophylaxis, to manage Candida colonization in cancer patients. A comprehensive literature search of studies published between 2015 and 2025 was conducted using Pub Med, Scopus, and Web of Science. Key findings were synthesized to understand the relationship between Candida infections and OSCC. The persistent Candida infections create a pro-tumorigenic microenvironment that accelerates dysplastic changes and malignant progression, particularly in high-risk individuals. While the direct causative relationship is complex, the combined effects of Candida , tobacco, alcohol use, and immunosuppression are significant in oral carcinogenesis. Early detection, antifungal treatments, and personalized therapies are essential to improving patient outcomes. A multidisciplinary approach involving oncologists, microbiologists, and immunologists is crucial for developing integrated strategies to manage both Candida infections and cancer. Future research should focus on dual-action therapies targeting both Candida -induced inflammation and tumor progression. • Persistent Candida albicans infections are strongly correlated with oral carcinogenesis. • Candida -induced inflammation promotes oxidative stress, cytokine imbalances, and genomic instability. • Biofilm formation, epithelial invasion, and immune evasion contribute to oral carcinogenesis. • Early detection and management of Candida infections and good oral hygiene are crucial for reducing the risk of oral cancer.
  • The impact of probiotics on oral cancer: Mechanistic insights and therapeutic strategies
    K.S. Lekshmi Priya, Datchanamoorthy Maheswary, Sujith Sri Surya Ravi, Kakithakara Vajravelu Leela, Rahul Harikumar Lathakumari, G. Malavika
    Oral Oncology Reports, 2025
    Oral cancer, especially oral squamous cell carcinoma (OSCC), represents a major global health concern, with its notable increase in incidence, especially among younger populations. The disease is multifactorial, with risk factors including tobacco and alcohol use, chronic inflammation, and dysbiosis of the oral microbiome. Probiotics, which are live microorganisms that provide health benefits, have gained attention as a potential approach for modulating the oral microbiome and reducing the risk of oral cancer. This review examines the mechanisms through which probiotics demonstrate anticancer properties, such as binding to and breaking down mutagenic substances, reducing gut pH via the production of short-chain fatty acids, and strengthening the immune response of the host. Specific probiotic strains, such as Lactobacillus and Bifidobacterium , have demonstrated potential in managing oral cancer and its treatment-related complications, such as oral mucositis. Clinical trials suggest that probiotics could act as valuable complementary agents to conventional cancer treatments, enhancing patient outcomes and quality of life. Despite the promising findings, challenges remain in standardizing probiotic formulations and understanding strain-specific effects. Future research should focus on personalized probiotic therapies and innovative delivery systems to enhance their efficacy in oral cancer management. This narrative review emphasizes the potential of probiotics in the prevention and management of oral cancer, showcasing their contribution to oral health and their utility as biomarkers for early diagnosis. • Probiotics like Lactobacillus and Bifidobacterium modulate the oral microbiome, lowering oral cancer risk. • Probiotics bind mutagens, produce SCFAs, and boost immunity, aiding in cancer prevention. • Probiotics manage oral mucositis and enhance outcomes alongside cancer treatments. • Future Research focuses on personalized probiotics and better delivery for oral cancer care.
  • The gut virome and human health: From diversity to personalized medicine
    Rahul Harikumar Lathakumari, Leela Kakithakara Vajravelu, Anusha Gopinathan, Poornima Baskar Vimala, Vishnupriya Panneerselvam, Sujith Sri Surya Ravi, Jayaprakash Thulukanam
    Engineering Microbiology, 2025
    • The gut virome shapes bacterial populations, metabolism, and immunity, impacting health. • New sequencing technologies have advanced phage-based therapeutics and diagnostics. • Phageomics offers personalized therapies against antimicrobial resistance. • CRISPR-Cas systems and phage diagnostics target antibiotic resistance and pathogens. The human gut virome plays a crucial role in the gut and overall health; its diversity and regulatory functions influence bacterial populations, metabolism, and immune responses. Bacteriophages (phages) and eukaryotic viruses within the gut microbiome contribute to these processes, and recent advancements in sequencing technologies and bioinformatics have greatly expanded our understanding of the gut virome. These advances have led to the development of phage-based therapeutics, diagnostics, and artificial intelligence-driven precision medicine. The emerging field of phageomics shows promise for delivering personalized phage therapies that combat antimicrobial resistance by specifically targeting pathogenic bacteria while preserving beneficial microbes. Moreover, CRISPR-Cas systems delivered via phages have shown success in selectively targeting antibiotic resistance genes and enhancing treatment effectiveness. Phage-based diagnostics are highly sensitive in detecting bacterial pathogens, offering significant benefits for human health and zoonotic disease surveillance. This synthesis of the current knowledge highlights the pivotal role of the gut virome in regulating microbial communities and its transformative potential in personalized medicine, emphasizing its importance in advancing therapeutic and diagnostic strategies for improving health outcomes.
  • Epidemiological Trends in Pulmonary and Extra pulmonary Tuberculosis: A 5 year Retrospective Analysis of Acid Fast Bacilli
    Datchanamoorthy Maheswary, Sujith Sri Surya Ravi, Kakithakara Vajravelu Leela, Rahul Harikumar Lathakumari, Malavika Gireesan
    International Journal of Mycobacteriology, 2025
    Background: Tuberculosis (TB) remains a major public health issue globally, presenting in pulmonary tuberculosis(PTB) and extra PTB(EPTB) forms. Acid-Fast Bacilli (AFB) testing is crucial for detecting Mycobacterium tuberculosis. Understanding TB epidemiology, including positivity rates, demographic patterns, and comorbidities, is essential for effective control. This study analyses AFB testing trends for TB over 5 years, focusing on PTB and EPTB cases, gender and age distribution, and associated comorbidities to inform public health and clinical practices. Methods: This retrospective study analyzed AFB, Mantoux, and polymerase chain reaction (PCR) testing data from 2019 to 2023. Trends in positivity rates, PTB/EPTB ratios, demographics, and comorbidities were assessed, with statistical analyses and comparisons to prior studies to contextualize findings. Results: AFB testing volume rose from 2440 samples in 2019–2518 in 2023. PTB positivity declined from 3.7% to 2.5%, whereas EPTB cases peaked in 2020. Males predominated PTB cases, peaking at 84.62% in 2020. PTB to EPTB ratios were 12.82:1 (AFB) and 3.47:1 (PCR). Mantoux positivity rose significantly from 2019 to 2022 (χ² =18.64, P < 0.001), with higher rates in males and older adults. An increase in rifampicin-resistant TB was noted in 2022–2023. Common TB comorbidities included diabetes, hypertension, and chronic lung disease, complicating treatment. Conclusion: This study highlights dynamic TB trends, stressing the need for age- and gender-specific control strategies. Rising EPTB cases, drug resistance, and comorbidities underscore the importance of targeted interventions, preventive measures, and socioeconomic research to optimize TB management.
  • Association of Robust Anti-SARS-CoV-2 Trajectories among Communities with and without COVID-19 Infection
    Balamurali Venkatesan, Leela Kakithakara Vajravelu, Sujith Ravi, Jayaprakash Thulukanam, Om Lokesh Muthamilan
    Journal of Pure and Applied Microbiology, 2024
    Globally, 767 million people have been affected by SARS-CoV-2 infection and nearly a population of 6.94 million were deceased as per the World Health Organization (WHO) as of June 7, 2023. In India, the spreading of infections is now being restricted by the use of BBV-152 (CovaxinTM) and ChAdOx1-nCOV (CovishieldTM) vaccines. The present study comprises 327 candidates and Chemiluminescent microparticle immunoassay (CMIA) was used as a quantitative analytical tool to detect IgG and IgM antibodies. Out of 327 candidates, 177 (54.1%) were vaccinated and 150 (45.9%) were non-vaccinated. Among vaccinated and non-vaccinated candidates, 49 (27.7%%) and 44 (29.3%) had a history of infection, respectively; meanwhile, most of the study participants were immunized with CovishieldTM (n=145, 81.9%) and 18.1% (n=32) were immunized with CovaxinTM. There were insignificant differences observed among immunized as well as non-immunized study participants in considering median age, gender, age categories, IgM levels, or IgM seropositivity. Predictably, there was an important variation in IgG median values and IgG positivity noticed among the immunized and non-immunized categories as well as between populations with and without preceding infections. Our research is hence coherent with prospective requirements for booster shots to assist in controlling the rate of infections and fatality rates together throughout the pandemic conditions.
  • Antibiotics and the gut microbiome: Understanding the impact on human health
    Rahul Harikumar Lathakumari, L. Vajravelu, Abhishek Satheesan, S. Ravi, Jayaprakash Thulukanam
    Medicine in Microecology, 2024
    Antibiotic use has become problematic because it unintentionally upsets the delicate equilibrium of the human gut microbiota. Antibiotics, especially broad-spectrum ones, that were once regarded as life-saving treatments for bacterial infections instead indiscriminately destroy the good bacteria that are essential for preserving gut health in addition to their target pathogens. Antibiotic-induced gut dysbiosis, the term for this disturbance, sets off a series of adverse reactions that negatively impact the gut microbiome, resulting in a decline in microbial diversity and the creation of an environment that is favourable to the establishment of strains that are resistant to antibiotics. Antibiotic exposure has wide-ranging effects from prenatal to adulthood; research has shown long-term effects include increased risk of antibiotic resistance, obesity, allergies, asthma, and altered metabolic processes. This thorough investigation emphasises the critical need for a more sophisticated knowledge of the effects of antibiotic therapy on the gut microbiota and the necessity of implementing all-encompassing solutions that reduce its detrimental effects and protect human health throughout life.
  • Correlation of Robust Immune Response against SARS-CoV-2 Vaccine among Diabetic and Non-Diabetic Participants
    Balamurali Venkatesan, L. Vajravelu, S. Ravi, Jayaprakash Thulukanam, Om Lokesh Muthamilan
    Biomedical and Pharmacology Journal, 2024
    Individuals with Type-2 diabetic mellitus (T2DM) along with several other disease-causing factors are impacted adversely by the SARS-CoV-2 pandemic. In India, BBV-152 (CovaxinTM) and ChAdOx1-nCOV (CovishieldTM) vaccines are now being used to limit the spread of SARS-CoV-2 Infection. Adaptive immunity like humoral and T-cell-mediated immunity has a vital role in eliminating SARS-CoV-2. In order to control the disease's course, the infected cells are being destroyed predominantly by cytotoxic CD8+ T cells as well as specific antibodies against SARS-CoV-2 which have the potential to neutralize the virus. This cross-sectional study was done to identify the specific antibodies for SARS-CoV-2 in serum samples from those individuals with and without T2DM by using WANTAI SARS-CoV-2 Total Ab ELISA Kit. The present study comprises 354 study participants, among them T2DM was present in 141 (39.8%) cases and 213 (60.2%) were non-diabetic patients. Hypertension was observed in 95 (26.1%) participants and 259 (73.1%) participants were normotensive. The study participants with T2DM demonstrated lower levels of SARS-CoV-2 total antibodies having an average of 5 AU/ml over those individuals without diabetes showing an average of 12 AU/ml. Among the hypertensive patients, the total antibody levels of SARS-CoV2 are were substantially lowered to showing an average of 8 AU/ml as compared to normotensive subjects showing an average of 14 AU/ml. The results of the current study suggest that regular monitoring of the total SARS-CoV-2 antibody profile may be a useful strategy for assisting people with T2DM and hypertension in determining whether they require SARS-CoV-2 precautionary doses to maintain immunity and protect against infections.
  • Green Synthesis of Iron Oxide Nanoparticles and Their Antibacterial Efficacy against Carbapenem-resistant Klebsiella pneumoniae in Bloodstream Infections
    Rahul Harikumar Lathakumari, Leela Kakithakara Vajravelu, Jayaprakash Thulukanam, Vishnupriya Panneerselvam, Poornima Baskar Vimala, Dakshina Manoj Nair, Sujith Sri Surya Ravi
    Biomedical and Biotechnology Research Journal, 2024
    Background: Carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a significant threat to global public health by rendering traditional antibiotic treatments ineffective. The increasing resistance to carbapenems and other critical antibiotics highlights an urgent need for alternative therapeutic strategies. Methods: We analyzed 180 Gram-negative bacilli isolates from blood specimens, of which 30 were identified as CRKP. Antibiotic susceptibility testing was conducted to determine resistance patterns, while genotypic analysis was performed to detect carbapenemase genes, including blaOXA-48, blaVIM, and blaNDM. In addition, we investigated the antibacterial potential of iron oxide nanoparticles (IONPs) synthesized through green methods using Chaetomorpha antennina (C. antennina). The minimum inhibitory concentration (MIC) for both bare and capped nanoparticles was determined to assess their effectiveness against CRKP. Results: The CRKP isolates exhibited total resistance to carbapenems, cefepime, ceftazidime, and piperacillin/tazobactam. Genotypic analysis revealed the presence of blaOXA-48 in 100% of isolates, blaVIM in 93%, and blaNDM in 70%, indicating a diverse array of carbapenemase genes. The green-synthesized IONPs demonstrated potent antibacterial activity against CRKP, with a MIC of 0.15 mg/mL, effectively reducing genomic resistance in the tested isolates. Conclusion: This study underscores the alarming prevalence of antibiotic resistance in CRKP and highlights the need for alternative therapeutic approaches. The promising results from the use of IONPs synthesized from C. antennina suggest that sustainable nanotechnology could be a viable intervention to combat carbapenem resistance in Klebsiella pneumoniae. These findings warrant further investigation into nanoparticle-based therapies for multidrug-resistant organisms.
  • A study of analysis on prevalence, serological marker and prognosis of tuberculosis in tertiary care hospital
    K. Sundaram, Leela Kagithakara Vajravelu, J. T, S. R
    Indian Journal of Tuberculosis, 2023
  • Correlation of Interleukin-17 and 23 Inflammatory Markers with Genetically Transmitted Spondyloarthritis Patients at a Tertiary Care Facility, South India
    T. Jayaprakash, K.V. Leela, Balamurali Venkatesan, Sujith Ravi, Om Lokesh Muthamilan
    Journal of Pure and Applied Microbiology, 2023
  • Analysis of Robust Immune Response among Diabetic and Non-Diabetic Individuals against SARS-CoV-2 Vaccination
    Balamurali Venkatesan, Leela Kakithakara Vajravelu, Sujith Ravi, Jayaprakash Thulukanam, Om Lokesh Muthamilan
    Journal of Pure and Applied Microbiology, 2023
  • Perspectives of Novel Drug Delivery in Mycoses
    D. Maheswary, Kakithakara Vajravelu Leela, Sujith Ravi
    Advances in Novel Formulations for Drug Delivery, 2023
  • Nano-Based Drug Delivery in Eliminating Tuberculosis
    Anusha Gopinathan, Shweta Sagar Naik, K.V. Leela, Sujith Ravi
    Advances in Novel Formulations for Drug Delivery, 2023
  • Promising Approaches in Drug Delivery Against Resistant Bacteria
    Shweta Sagar Naik, G. Anusha, Kakithakara Vajravelu Leela, Sujith Ravi
    Advances in Novel Formulations for Drug Delivery, 2023
  • Universal Coronavirus testing to Control the Pandemic: ethical Issues and Dilemmas
    A. Gopinathan, S. Naik, D. Maheswary, S. Ravi, K. V. Leela
    Journal of Pure and Applied Microbiology, 2022
  • Antibiotic Resistance of Clinical Klebsiella Isolates from tertiary Care Hospital
    Ramya Sivaramakrishnan, K.V. Leela, R. Sujith, Shweta Naik, Sneha Priya
    Journal of Pure and Applied Microbiology, 2022
  • Therapeutic and Diagnostic Approaches by using Nanotechnology in SARS-CoV-2 Infections
    Balamurali Venkatesan, Leela Kakithakara Vajravelu, Sujith Ravi, Jayaprakash Thulukanam, Om Lokesh Muthamilan
    Journal of Pure and Applied Microbiology, 2022
  • SARS-CoV-2 Non Responders - An Analysis of Non Responsiveness to SARS-CoV-2 Vaccines among Healthcare Workers in 2021
    Balamurali Venkatesan, Leela Kakithakara Vajravelu, Sujith Ravi, Jayaprakash Thulukanam, Om Lokesh Muthamilan
    Journal of Pure and Applied Microbiology, 2022
  • Association of Genetic Marker HLA-B27 with Spondyloarthritis In A Tertiary Care Centre In South India
    T. Jayaprakash, Om Lokesh Muthamilan, K.V. Leela, C. Panchapakesa Rajendran, Arul Raja Murugan, Sujith Ravi
    Journal of Pure and Applied Microbiology, 2022
  • Occurrence and Resistance Pattern of Gram-Negative Bacteremia and Sepsis in A Tertiary Care Hospital - A Four-Year Study
    Alamu Juliana, K.V. Leela, Anusha Gopinathan, R. Sujith
    Journal of Pure and Applied Microbiology, 2022
  • Consumer Nanoproducts in Antimicrobial Application
    Sujith Ravi, Ishwarya R. Kishore
    Handbook of Consumer Nanoproducts, 2022
  • A study on prevalence and characterization of Candida species in immunocompromised patients
    Dhanapal Nandini, J. Manonmoney, J. Lavanya, K.V. Leela, Sujith
    Journal of Pure and Applied Microbiology, 2021
  • Suitability of PEG capped carboxylic acid terminated fluorescent ZnS nanoparticles for NDV peptide binding
    N. Deepa, K. Aanantharaj, A. Vimala Juliet, R. Sujith, Jositta Sherine
    Applied Nanoscience Switzerland, 2021
  • Ergonomic diagnostic tool based on chip mini RT-PCR for diagnosis of pulmonary and extra pulmonary tuberculosis
    V Mangayarkarasi, Sneka P, Sujith R, Jayaprakash Jayaprakash
    Journal of Pure and Applied Microbiology, 2019

RECENT SCHOLAR PUBLICATIONS

  • Comparative Analysis of Biofilm Formation in Bacterial and Fungal Isolates from Contact Lens and Non-Contact Lens Associated Keratitis
    KS Abraham, SS Surya Ravi, LK Vajravelu
    medRxiv, 2026.02. 09.26345896 , 2026
    2026
  • Diagnostic and therapeutic challenges in melioidosis: a case series from South India
    DM Nair, A Gopinathan, LK Vajravelu, C Mukhopadhyay, R Santharam, ...
    Reviews and Research in Medical Microbiology, 10.1097 , 2026
    2026
  • Role of Candida albicans in chronic inflammation and the development of oral squamous cell carcinoma
    G Malavika, SSS Ravi, D Maheswary, KV Leela, RH Lathakumari, ...
    Cancer Pathogenesis and Therapy 3 (05), 402-410 , 2025
    2025
    Citations: 15
  • The gut virome and human health: From diversity to personalized medicine
    RH Lathakumari, LK Vajravelu, A Gopinathan, PB Vimala, ...
    Engineering Microbiology 5 (1), 100191 , 2025
    2025
    Citations: 22
  • The impact of probiotics on oral cancer: Mechanistic insights and therapeutic strategies
    KSL Priya, D Maheswary, SSS Ravi, KV Leela, RH Lathakumari, ...
    Oral Oncology Reports 13, 100715 , 2025
    2025
    Citations: 15
  • Epidemiological trends in pulmonary and extra pulmonary tuberculosis: A 5 year retrospective analysis of acid fast bacilli
    D Maheswary, SSS Ravi, KV Leela, RH Lathakumari, M Gireesan
    The International Journal of Mycobacteriology 14 (1), 56-65 , 2025
    2025
    Citations: 2
  • Comparative evaluation of microleakage in class V cavities restored with newer bioactive restorative materials: Activa bioactive restorative and activa pronto
    TV Pracheth, VS Pai, B Vedavathi, P Girish, R Sujith, A Bhaskar, ...
    International Journal of Clinical Pediatric Dentistry 17 (11), 1272 , 2024
    2024
    Citations: 5
  • Rise of Carbapenem-Resistant Escherichia coli and the Concerning Existence of blaNDM-1 Gene in Gut Microbiota of Rural Populations
    A Yadhunandan, RSS Surya, LK Vajravelu, B Venkatesan, P Deeksha, ...
    J Pure Appl Microbiol , 2024
    2024
  • Green synthesis of iron oxide nanoparticles and their antibacterial efficacy against carbapenem-resistant Klebsiella pneumoniae in bloodstream infections
    RH Lathakumari, LK Vajravelu, J Thulukanam, V Panneerselvam, ...
    Biomedical and Biotechnology Research Journal (BBRJ) 8 (4), 493-499 , 2024
    2024
    Citations: 1
  • Association of Robust Anti-SARS-CoV-2 Trajectories among Communities with and without COVID-19 Infection
    B Venkatesan, LK Vajravelu, S Ravi, J Thulukanam, OL Muthamilan
    Journal of Pure and Applied Microbiology 18 (3), 1558-1565 , 2024
    2024
  • Comparative evaluation of clinical and microbiological assessment of caries excavation using conventional, smart bur, chemomechanical method and ErCr: YSGG laser
    A Kini, P Kothari, R Sujith, N Shetty, BK Varughese, SC Kasargod
    Journal of Pharmacy and Bioallied Sciences 16 (Suppl 3), S2830-S2832 , 2024
    2024
    Citations: 1
  • Antibiotics and the gut microbiome: Understanding the impact on human health
    RH Lathakumari, LK Vajravelu, A Satheesan, S Ravi, J Thulukanam
    Medicine in Microecology 20, 100106 , 2024
    2024
    Citations: 137
  • Correlation of Robust Immune Response against SARS-CoV-2 Vaccine among Diabetic and Non-Diabetic Participants
    B Venkatesan, LK Vajravelu, S Ravi, J Thulukanam, OL Muthamilan
    Biomedical and Pharmacology Journal 17 (1), 401-407 , 2024
    2024
  • A study of analysis on prevalence, serological marker and prognosis of tuberculosis in tertiary care hospital
    K Sundaram, LK Vajravelu, J Thulukanam, S Ravi
    Indian Journal of Tuberculosis 70 (4), 398-404 , 2023
    2023
    Citations: 1
  • Correlation of interleukin-17 and 23 inflammatory markers with genetically transmitted spondyloarthritis patients at a tertiary care facility, South India
    LK Jayaprakash, B Venkatesan, S Ravi, O Muthamilan
    J Pure Appl Microbiol 17 (2), 1038-1046 , 2023
    2023
    Citations: 2
  • Promising approaches in drug delivery against resistant bacteria
    SS Naik, G Anusha, KV Leela, S Ravi
    Advances in novel formulations for drug delivery, 219-229 , 2023
    2023
    Citations: 10
  • Nano‐Based Drug Delivery in Eliminating Tuberculosis
    A Gopinathan, SS Naik, KV Leela, S Ravi
    Advances in Novel Formulations for Drug Delivery, 207-218 , 2023
    2023
    Citations: 5
  • Perspectives of Novel Drug Delivery in Mycoses
    D Maheswary, KV Leela, S Ravi
    Advances in Novel Formulations for Drug Delivery, 197-205 , 2023
    2023
    Citations: 1
  • Analysis of robust immune response among diabetic and non-diabetic individuals against SARS-COV-2 vaccination
    B Venkatesan, LK Vajravelu, S Ravi, J Thulukanam, OL Muthamilan
    J Pure Appl Microbiol 17 (1), 395-402 , 2023
    2023
    Citations: 3
  • Advances in Novel Formulations for Drug Delivery
    SS Naik, G Anusha, KV Leela, S Ravi
    Willey , 2023
    2023
    Citations: 7

MOST CITED SCHOLAR PUBLICATIONS

  • Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch …
    LM Fernandez, GP São Julião, NL Figueiredo, GL Beets, ...
    The Lancet Oncology 22 (1), 43-50 , 2021
    2021
    Citations: 232
  • Antibiotics and the gut microbiome: Understanding the impact on human health
    RH Lathakumari, LK Vajravelu, A Satheesan, S Ravi, J Thulukanam
    Medicine in Microecology 20, 100106 , 2024
    2024
    Citations: 137
  • The gut virome and human health: From diversity to personalized medicine
    RH Lathakumari, LK Vajravelu, A Gopinathan, PB Vimala, ...
    Engineering Microbiology 5 (1), 100191 , 2025
    2025
    Citations: 22
  • Jayaprakash Ergonomic diagnostic tool based on chip mini RT-PCR for diagnosis of pulmonary and extra pulmonary tuberculosis
    V Mangayarkarasi, P Sneka, R Sujith
    J Pure Appl Microbiol 13 (2), 1185-1190 , 2019
    2019
    Citations: 21
  • Role of Candida albicans in chronic inflammation and the development of oral squamous cell carcinoma
    G Malavika, SSS Ravi, D Maheswary, KV Leela, RH Lathakumari, ...
    Cancer Pathogenesis and Therapy 3 (05), 402-410 , 2025
    2025
    Citations: 15
  • The impact of probiotics on oral cancer: Mechanistic insights and therapeutic strategies
    KSL Priya, D Maheswary, SSS Ravi, KV Leela, RH Lathakumari, ...
    Oral Oncology Reports 13, 100715 , 2025
    2025
    Citations: 15
  • Handbook of consumer nanoproducts
    S Mallakpour, CM Hussain
    Springer 10, 978-981 , 2022
    2022
    Citations: 12
  • Promising approaches in drug delivery against resistant bacteria
    SS Naik, G Anusha, KV Leela, S Ravi
    Advances in novel formulations for drug delivery, 219-229 , 2023
    2023
    Citations: 10
  • Sujith. A Study on Prevalence and Characterization of Candida Species in Immunocompromised Patients
    D Nandini, J Manonmoney, J Lavanya, KV Leela
    J. Pure Appl. Microbiol 15, 2065-2072 , 2021
    2021
    Citations: 10
  • Caries vaccine–A review
    R Sujith, S Naik, P Rajanikanth
    Indian Journal of Mednodent and Allied Sciences 2 (2), 198-203 , 2014
    2014
    Citations: 9
  • Advances in Novel Formulations for Drug Delivery
    SS Naik, G Anusha, KV Leela, S Ravi
    Willey , 2023
    2023
    Citations: 7
  • Efficacy of Green Synthesised Iron Oxide Nanoparticles against Various Uropathogens: A Cross-sectional Study.
    RH LATHAKUMARI, S RAVI, S TRISAL, LK VAJRAVELU, ...
    Journal of Clinical & Diagnostic Research 16 (10) , 2022
    2022
    Citations: 7
  • Occurrence and resistance pattern of Gram-negative bacteremia and sepsis in a tertiary care hospital-a four-year study
    A Juliana, KV Leela, A Gopinathan, R Sujith
    J. Pure Appl. Microbiol 16, 655-662 , 2022
    2022
    Citations: 6
  • Comparative evaluation of microleakage in class V cavities restored with newer bioactive restorative materials: Activa bioactive restorative and activa pronto
    TV Pracheth, VS Pai, B Vedavathi, P Girish, R Sujith, A Bhaskar, ...
    International Journal of Clinical Pediatric Dentistry 17 (11), 1272 , 2024
    2024
    Citations: 5
  • Nano‐Based Drug Delivery in Eliminating Tuberculosis
    A Gopinathan, SS Naik, KV Leela, S Ravi
    Advances in Novel Formulations for Drug Delivery, 207-218 , 2023
    2023
    Citations: 5
  • Mandibular second molar with single root and single canal-A case report
    R Sujith, D Kiranmurthy
    International Journal of Contemporary Dentistry 2 (5) , 2011
    2011
    Citations: 5
  • Therapeutic and diagnostic approaches by using nanotechnology in SARS-COV-2 infections
    B Venkatesan, LK Vajravelu, S Ravi, J Thulukanam, OL Muthamilan
    J Pure Appl Microbiol 16 (4), 2324-2336 , 2022
    2022
    Citations: 4
  • Association of Genetic Marker HLA-B27 with Spondyloarthritis In A Tertiary Care Centre In South India.
    T Jayaprakash, OL Muthamilan, KV Leela, CP Rajendran, AR Murugan, ...
    Journal of Pure & Applied Microbiology 16 (2) , 2022
    2022
    Citations: 4
  • SARS-CoV-2 Non Responders–an Analysis of Non Responsiveness to SARS-CoV-2 Vaccines among Healthcare Workers in 2021
    B Venkatesan, LK Vajravelu, S Ravi, J Thulukanam, OL Muthamilan
    J Pure Appl Microbiol 16 (2), 1187-1191 , 2022
    2022
    Citations: 4
  • Suitability of PEG capped carboxylic acid terminated fluorescent ZnS nanoparticles for NDV peptide binding
    N Deepa, K Aanantharaj, A Vimala Juliet, R Sujith, J Sherine
    Applied Nanoscience 11 (8), 2337-2346 , 2021
    2021
    Citations: 4